Skip to content

Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty

Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02597673
Enrollment
132
Registered
2015-11-05
Start date
2015-07-31
Completion date
2018-05-31
Last updated
2020-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Brief summary

The overall objective of this project is to compare the three home-managed treatment regimens for PFPS: neuromuscular electrical stimulation (NMES), transcutaneous electrical nerve stimulation (TENS), and NMES combined with TENS to a standard home exercise program (HEP). Each of the three treatment arms will be supplemented by HEP and compared to a group receiving standard HEP alone. The central hypothesis is that the combination of NMES with TENS will show significantly greater improvements in muscle strength, mobility, pain, daily activity and quality of life (QOL) than HEP alone. The investigators are examining: 1) whether the three treatment regimens are significantly more efficacious than standard HEP alone in improving lower extremity muscle strength, physical activity, mobility, pain, and quality of life; 2) lower extremity muscle strength, physical activity, mobility, pain, and quality of life differ significantly across the 4 time periods; 3) is there an interaction between treatment and time in relation to lower extremity muscle strength, physical activity, mobility, pain, and quality of life.

Detailed description

Patellofemoral pain syndrome (PFPS) is the most common diagnosis among active duty military presenting with knee pain in the military ambulatory care setting. The incidence of PFPS has shown a striking increase of \>11.3% over the last 4 years, affecting work performance, limiting activity, and impacting military deployment health. The investigators have shown that home-based neuromuscular electrical stimulation (NMES) is safe, portable, easy-to-use and improves quadriceps muscle strength with some pain relief. NMES and transcutaneous electrical nerve stimulation (TENS) devices are widely used by warfighters in the theatre of operation for knee problems. The overall objective of this project is to compare three home-managed treatment regimens for PFPS: NMES, TENS, and NMES combined with TENS to a standard home exercise program (HEP). The central hypothesis is that the combination of NMES with TENS will show significantly greater improvements in muscle strength, mobility, pain, daily activity and quality of life (QOL) than HEP alone. The rationale for this study is that increasing muscle strength and decreasing pain will significantly improve mobility, physical activity and QOL. Such outcomes will ultimately result in improved deployability, retention of military personnel and decreased economic costs in this population. The specific aims are to determine whether the three treatment regimens are significantly more efficacious than standard HEP for improving muscle strength, physical activity, mobility, QOL and symptoms of PFPS including pain. After consent and baseline testing, the investigators will randomly assign active duty male and female subjects, ages 18 to \<45, (n=136) with PFPS to one of the four groups. Each of the three treatment arms will be supplemented by HEP and compared to a group receiving standard HEP alone. All groups will receive 9 weeks of home therapy. Using GEE methods, the investigators will build longitudinal regression models so that differences in time trends for the outcome variables among controls and those in the treatment groups can be statistically assessed. Positive results could translate into accelerated rehabilitation, decreased symptoms and lower medical costs with better patient outcomes.

Interventions

All participants will receive a standard home-based exercise rehabilitation protocol for PFPS. HEP teaches muscle strengthening exercises and self-management strategies to prevent recurrence. This program includes sessions with the study coordinator. A handout and given a demonstration of the daily exercises to be performed at home and weekly communication from the study coordinator regarding compliance with the exercises.

DEVICENMES

To ensure consistent interventions across participants, a specified percentage of baseline maximal voluntary contraction (% MVC) will be used to determine the intensity of the training contraction. The electrical amplitude to obtain the desired intensity will be determined for each participant. Participants will train at 20-30% of MVC during weeks 1-3, 30-40% of MVC during weeks 3-6, and 40-50% of MVC during weeks 6-9. Incremental increases will be made at the 3 and 6 week clinic visits. Individualized instructions for adjusting the amplitude dial settings, with a return demonstration, will be used to maintain the appropriate percentage of MVC. During the home training sessions, participants will adjust the amplitude required to achieve the desired goal, as tolerated.

DEVICETENS

The TENS protocol consists of 20-minutes of TENS stimulation while concurrently performing the HEP. The TENS with HEP and HEP alone will be alternated for 9 weeks. The Active device delivers a pre-set program of pulsed electrostimulation using a patented asymmetrical simple modulated pulse (SMP) waveform. SMP delivers a group of pulses as a repeating 12-second cycle.

Sponsors

Blanchfield Army Community Hospital
CollaboratorFED
University of Tennessee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

The study will be open to all active duty personal who are: 1. diagnosed with knee pain, categorized as anterior or retropatellar in one or both knees; 2. self-reported difficulty performing at least two or more of the following activities associated with knee pain: prolonged sitting, stair climbing, running, jumping and repetitive movements such as kneeling or squatting or stooping; 3. military service member at the time of diagnosis; 4. age ≥18 and \<45 years; and 5. ability to provide freely given informed consent.

Exclusion criteria

Those who might be at risk of adverse outcomes from the study interventions will be excluded. This includes individuals with 1. Fracture or injury to external knee structures such that knee extension or flexion is impaired; 2. A significant co-morbid medical condition (such as severe hypertension, neurological disorder or pacemaker/defibrillator) in which NMES strength training or unsupervised exercise is contraindicated and would pose a safety threat or impair ability to participate; 3. Previous knee surgeries (i.e., tibiofemoral, patellofemoral) excluding knee arthroscopy; 4. Knee instability or recurrent patella dislocation or subluxation; 5. Inability or unwillingness to participate in a home exercise program or strengthening program; 6. Inability to speak and/or read English; 7. Reduced sensory perception in the lower extremities; 8. Pregnancy; 9. Vision impairment, where participant is classified as legally blind; 10. Unwillingness to accept random assignment; or 11. A score of 23 or greater on the Center for Epidemiological Studies-Depression scale (CES-D).

Design outcomes

Primary

MeasureTime frameDescription
Lower Extremity Mobility- 6-Minute Walk Test0, 3, 6, and 9 weeksMobility was measured by the distance walked at a fast pace over 6-minutes.
Lower Extremity Muscle Strength- Extension0, 3, 6, and 9 weeksThe NMMT is a handheld device which measures knee extensor (KE) and flexor (KF) muscle strength. The measurement of KE strength on the PFPS leg is reported. For each test, participants performed three maximal efforts holding each contraction for 4 seconds, separated by 30-second rest; the highest value of the three trials will be accepted in kilograms.
Lower Extremity Muscle Strength- Flexion0, 3, 6, and 9 weeksThe NMMT is a handheld device which measures knee extensor (KE) and flexor (KF) muscle strength. The measurement of KE strength on the PFPS leg is reported. For each test, participants performed three maximal efforts holding each contraction for 4 seconds, separated by 30-second rest; the highest value of the three trials will be accepted in kilograms.
Lower Extremity Strength- 30-Second Chair Stand Test0, 3, 6, and 9 weeksMobility was measured by the number of complete standing and sitting cycles in 30-seconds
Lower Extremity Strength- Timed Stair Climb Test0, 3, 6, and 9 weeksStrength, balance, and power were measured by the number seconds it took to ascend and descend 4 steps (6 in rise, 11.5 in run).
Lower Extremity Mobility- Forward Step-down Test0, 3, 6, and 9 weeksMobility was measured by the number of step down repetitions completed in 30 seconds.

Secondary

MeasureTime frameDescription
Knee Pain Following Performance Testing- 30-Second Chair Stand Test0, 3, 6, and 9 weeksKnee pain intensity after the 30-Second Chair Stand Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.
Knee Pain Following Performance Testing- Stair Climb Test0, 3, 6, and 9 weeksKnee pain intensity after the Stair Climb Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.
Knee Pain Following Performance Testing- Forward Step Down Test0, 3, 6, and 9 weeksKnee pain intensity after the Forward Step Down Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.
Knee Pain Following Performance Testing- 6-Minute Walk Test0, 3, 6, and 9 weeksKnee pain intensity after the 6-Minute Walk Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.
Current Knee Pain0, 3, 6, and 9 weeksCurrent Knee Pain was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.

Countries

United States

Participant flow

Pre-assignment details

2 participants withdrew from the study during baseline testing, and prior to being assigned to a group.

Participants by arm

ArmCount
Standard Rehabilitation Protocol
Home Exercise Program (HEP): HEP taught muscle strengthening exercises and self-management strategies. The exercises were quadriceps strengthening exercises that consist of stretching exercises of the quadriceps and hamstring muscles and a combination of open chain and closed chain exercises. The combined open and closed chain exercises were active straight leg raises, quadriceps straightening, step up, and squats.
34
Self-Managed NMES Program
Neuromuscular electrical stimulation (NMES): NMES training consisted of 20-minute sessions performed concurrently with the HEP for 9 weeks; each 20-minute NMES session included a 2-minute warm-up, a 15-minute work-out and a 3-minute cool down. NMES with the thigh garment was used as the participant is performing the home exercises of stretching and combined open and closed chain exercises. Those in the NMES group received alternate HEP alone and NMES with HEP for a total of 62 sessions (31 sessions of NMES/HEP and 31 sessions HEP alone). Home Exercise Program (HEP): HEP taught muscle strengthening exercises and self-management strategies. The exercises were quadriceps strengthening exercises that consist of stretching exercises of the quadriceps and hamstring muscles and a combination of open chain and closed chain exercises. The combined open and closed chain exercises were active straight leg raises, quadriceps straightening, step up, and squats.
33
Self-Managed TENS Program
Transcutaneous electrical nerve stimulation (TENS). The TENS treatment groups received the battery-operated Kneehab® XP with lead wire TENS applicator system. The TENS protocol consisted of 20-minutes of TENS stimulation while concurrently performing the HEP. The TENS with HEP and HEP alone was alternated for 9 weeks for a total of 31 TENS/HEP sessions and 31 HEP alone for a total of 62 sessions. Home Exercise Program (HEP): HEP taught muscle strengthening exercises and self-management strategies. The exercises were quadriceps strengthening exercises that consist of stretching exercises of the quadriceps and hamstring muscles and a combination of open chain and closed chain exercises. The combined open and closed chain exercises were active straight leg raises, quadriceps straightening, step up, and squats.
33
Combined NMES/TENS Program
The combined NMES/TENS treatment group received the Kneehab® XP with the conductive thigh garment and the lead wire TENS applicator. The same parameters for TENS and NMES were used (described above). The NMES and the TENS protocol were performed on alternating days. There was a total of 31 NMES sessions with HEP and 31 TENS sessions with HEP for a total of 62 sessions. Home Exercise Program (HEP): HEP taught muscle strengthening exercises and self-management strategies. The exercises were quadriceps strengthening exercises that consist of stretching exercises of the quadriceps and hamstring muscles and a combination of open chain and closed chain exercises. The combined open and closed chain exercises were active straight leg raises, quadriceps straightening, step up, and squats.
30
Total130

Baseline characteristics

CharacteristicTotalSelf-Managed NMES ProgramSelf-Managed TENS ProgramStandard Rehabilitation ProtocolCombined NMES/TENS Program
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
130 Participants33 Participants33 Participants34 Participants30 Participants
Height176 cm
STANDARD_DEVIATION 9.5
174 cm
STANDARD_DEVIATION 10.8
177 cm
STANDARD_DEVIATION 8.1
176 cm
STANDARD_DEVIATION 11.2
175 cm
STANDARD_DEVIATION 7.37
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants0 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
5 Participants2 Participants2 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
41 Participants5 Participants11 Participants12 Participants13 Participants
Race (NIH/OMB)
More than one race
12 Participants5 Participants4 Participants3 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
White
70 Participants21 Participants15 Participants17 Participants17 Participants
Region of Enrollment
United States
130 participants33 participants33 participants34 participants30 participants
Sex: Female, Male
Female
29 Participants8 Participants7 Participants8 Participants6 Participants
Sex: Female, Male
Male
101 Participants25 Participants26 Participants26 Participants24 Participants
Weight85.3 kg
STANDARD_DEVIATION 15.4
85 kg
STANDARD_DEVIATION 16.1
86 kg
STANDARD_DEVIATION 14.4
86 kg
STANDARD_DEVIATION 16.7
84 kg
STANDARD_DEVIATION 14.8

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 340 / 330 / 330 / 30
other
Total, other adverse events
0 / 340 / 330 / 330 / 30
serious
Total, serious adverse events
0 / 340 / 330 / 330 / 30

Outcome results

Primary

Lower Extremity Mobility- 6-Minute Walk Test

Mobility was measured by the distance walked at a fast pace over 6-minutes.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Mobility- 6-Minute Walk TestWeek 024612 InchesStandard Deviation 2964
Standard Rehabilitation ProtocolLower Extremity Mobility- 6-Minute Walk TestWeek 324373 InchesStandard Deviation 3053
Standard Rehabilitation ProtocolLower Extremity Mobility- 6-Minute Walk TestWeek 624970 InchesStandard Deviation 2582
Standard Rehabilitation ProtocolLower Extremity Mobility- 6-Minute Walk TestWeek 925059 InchesStandard Deviation 3073
Self-Managed NMES ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 324919 InchesStandard Deviation 2804
Self-Managed NMES ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 625772 InchesStandard Deviation 3204
Self-Managed NMES ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 925892 InchesStandard Deviation 3300
Self-Managed NMES ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 023931 InchesStandard Deviation 2772
Self-Managed TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 625284 InchesStandard Deviation 3426
Self-Managed TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 324951 InchesStandard Deviation 3407
Self-Managed TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 925847 InchesStandard Deviation 3763
Self-Managed TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 023999 InchesStandard Deviation 2979
Combined NMES/TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 925227 InchesStandard Deviation 2655
Combined NMES/TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 324102 InchesStandard Deviation 2996
Combined NMES/TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 023174 InchesStandard Deviation 2638
Combined NMES/TENS ProgramLower Extremity Mobility- 6-Minute Walk TestWeek 624753 InchesStandard Deviation 2311
Primary

Lower Extremity Mobility- Forward Step-down Test

Mobility was measured by the number of step down repetitions completed in 30 seconds.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Mobility- Forward Step-down TestWeek 617.0 Number of RepetitionsStandard Deviation 4.9
Standard Rehabilitation ProtocolLower Extremity Mobility- Forward Step-down TestWeek 917.7 Number of RepetitionsStandard Deviation 5.2
Standard Rehabilitation ProtocolLower Extremity Mobility- Forward Step-down TestWeek 013.2 Number of RepetitionsStandard Deviation 3.9
Standard Rehabilitation ProtocolLower Extremity Mobility- Forward Step-down TestWeek 315.4 Number of RepetitionsStandard Deviation 5
Self-Managed NMES ProgramLower Extremity Mobility- Forward Step-down TestWeek 614.0 Number of RepetitionsStandard Deviation 5.6
Self-Managed NMES ProgramLower Extremity Mobility- Forward Step-down TestWeek 312.9 Number of RepetitionsStandard Deviation 4.3
Self-Managed NMES ProgramLower Extremity Mobility- Forward Step-down TestWeek 011.3 Number of RepetitionsStandard Deviation 3.6
Self-Managed NMES ProgramLower Extremity Mobility- Forward Step-down TestWeek 916.3 Number of RepetitionsStandard Deviation 5.3
Self-Managed TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 613.9 Number of RepetitionsStandard Deviation 5.4
Self-Managed TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 010.8 Number of RepetitionsStandard Deviation 4.9
Self-Managed TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 311.8 Number of RepetitionsStandard Deviation 4.8
Self-Managed TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 914.9 Number of RepetitionsStandard Deviation 5.7
Combined NMES/TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 011.2 Number of RepetitionsStandard Deviation 4
Combined NMES/TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 615.3 Number of RepetitionsStandard Deviation 4.9
Combined NMES/TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 918.0 Number of RepetitionsStandard Deviation 6
Combined NMES/TENS ProgramLower Extremity Mobility- Forward Step-down TestWeek 314.4 Number of RepetitionsStandard Deviation 5.6
Primary

Lower Extremity Muscle Strength- Extension

The NMMT is a handheld device which measures knee extensor (KE) and flexor (KF) muscle strength. The measurement of KE strength on the PFPS leg is reported. For each test, participants performed three maximal efforts holding each contraction for 4 seconds, separated by 30-second rest; the highest value of the three trials will be accepted in kilograms.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionInjured Knee: Week 341.41 Kg-ForceStandard Deviation 14.92
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 045.07 Kg-ForceStandard Deviation 17.83
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 342.81 Kg-ForceStandard Deviation 15.79
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionInjured Knee: Week 041.58 Kg-ForceStandard Deviation 16.56
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 943.83 Kg-ForceStandard Deviation 14.72
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionInjured Knee: Week 644.35 Kg-ForceStandard Deviation 12.4
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionInjured Knee: Week 941.78 Kg-ForceStandard Deviation 13.46
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 642.74 Kg-ForceStandard Deviation 14.5
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 037.74 Kg-ForceStandard Deviation 15.39
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 946.22 Kg-ForceStandard Deviation 18.31
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 044.56 Kg-ForceStandard Deviation 18.75
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 643.31 Kg-ForceStandard Deviation 17.52
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 342.70 Kg-ForceStandard Deviation 18.66
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 947.87 Kg-ForceStandard Deviation 20.64
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 347.16 Kg-ForceStandard Deviation 19.24
Self-Managed NMES ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 647.58 Kg-ForceStandard Deviation 18.51
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 346.64 Kg-ForceStandard Deviation 18.58
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 646.31 Kg-ForceStandard Deviation 16.6
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 946.69 Kg-ForceStandard Deviation 18.93
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 343.21 Kg-ForceStandard Deviation 21.49
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 037.14 Kg-ForceStandard Deviation 15.36
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 641.67 Kg-ForceStandard Deviation 20.6
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 945.44 Kg-ForceStandard Deviation 23.16
Self-Managed TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 043.75 Kg-ForceStandard Deviation 17.33
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 950.62 Kg-ForceStandard Deviation 18.32
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 040.42 Kg-ForceStandard Deviation 18.87
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 343.07 Kg-ForceStandard Deviation 17.8
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 643.03 Kg-ForceStandard Deviation 16.54
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionInjured Knee: Week 946.89 Kg-ForceStandard Deviation 17.78
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 045.42 Kg-ForceStandard Deviation 18.67
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 344.61 Kg-ForceStandard Deviation 18.6
Combined NMES/TENS ProgramLower Extremity Muscle Strength- ExtensionUnaffected Knee: Week 646.14 Kg-ForceStandard Deviation 15.84
Primary

Lower Extremity Muscle Strength- Flexion

The NMMT is a handheld device which measures knee extensor (KE) and flexor (KF) muscle strength. The measurement of KE strength on the PFPS leg is reported. For each test, participants performed three maximal efforts holding each contraction for 4 seconds, separated by 30-second rest; the highest value of the three trials will be accepted in kilograms.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 924.54 Kg-ForceStandard Deviation 8.27
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionInjured Knee: Week 622.84 Kg-ForceStandard Deviation 7.36
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 625.13 Kg-ForceStandard Deviation 8.8
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 324.71 Kg-ForceStandard Deviation 8.58
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 023.89 Kg-ForceStandard Deviation 7.2
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionInjured Knee: Week 021.85 Kg-ForceStandard Deviation 7.61
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionInjured Knee: Week 924.15 Kg-ForceStandard Deviation 9.67
Standard Rehabilitation ProtocolLower Extremity Muscle Strength- FlexionInjured Knee: Week 322.07 Kg-ForceStandard Deviation 8.05
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 020.32 Kg-ForceStandard Deviation 7.35
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 322.49 Kg-ForceStandard Deviation 8.76
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 623.72 Kg-ForceStandard Deviation 7.35
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 926.95 Kg-ForceStandard Deviation 8.17
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 023.11 Kg-ForceStandard Deviation 7.3
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 324.93 Kg-ForceStandard Deviation 8.49
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 624.64 Kg-ForceStandard Deviation 7.53
Self-Managed NMES ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 926.21 Kg-ForceStandard Deviation 8.16
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 024.34 Kg-ForceStandard Deviation 7.5
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 925.01 Kg-ForceStandard Deviation 9.11
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 021.33 Kg-ForceStandard Deviation 7.13
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 322.99 Kg-ForceStandard Deviation 8.04
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 925.30 Kg-ForceStandard Deviation 8.3
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 622.43 Kg-ForceStandard Deviation 8.76
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 323.93 Kg-ForceStandard Deviation 7.95
Self-Managed TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 623.65 Kg-ForceStandard Deviation 8.61
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 021.95 Kg-ForceStandard Deviation 9.13
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 926.96 Kg-ForceStandard Deviation 8.53
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 625.20 Kg-ForceStandard Deviation 7.79
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 025.20 Kg-ForceStandard Deviation 8.67
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 926.64 Kg-ForceStandard Deviation 10.02
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionUnaffected Knee: Week 324.40 Kg-ForceStandard Deviation 8.43
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 322.56 Kg-ForceStandard Deviation 8.84
Combined NMES/TENS ProgramLower Extremity Muscle Strength- FlexionInjured Knee: Week 623.86 Kg-ForceStandard Deviation 8.47
Primary

Lower Extremity Strength- 30-Second Chair Stand Test

Mobility was measured by the number of complete standing and sitting cycles in 30-seconds

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Strength- 30-Second Chair Stand TestWeek 011.6 risesStandard Deviation 2.8
Standard Rehabilitation ProtocolLower Extremity Strength- 30-Second Chair Stand TestWeek 313.2 risesStandard Deviation 3.5
Standard Rehabilitation ProtocolLower Extremity Strength- 30-Second Chair Stand TestWeek 614.2 risesStandard Deviation 3.4
Standard Rehabilitation ProtocolLower Extremity Strength- 30-Second Chair Stand TestWeek 915.3 risesStandard Deviation 4
Self-Managed NMES ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 312.3 risesStandard Deviation 4
Self-Managed NMES ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 612.8 risesStandard Deviation 4.4
Self-Managed NMES ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 914.4 risesStandard Deviation 4.4
Self-Managed NMES ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 011.0 risesStandard Deviation 3
Self-Managed TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 613.0 risesStandard Deviation 2.9
Self-Managed TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 311.7 risesStandard Deviation 3
Self-Managed TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 913.4 risesStandard Deviation 3.5
Self-Managed TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 011.0 risesStandard Deviation 3.1
Combined NMES/TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 915.1 risesStandard Deviation 4.8
Combined NMES/TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 312.6 risesStandard Deviation 4.1
Combined NMES/TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 011.0 risesStandard Deviation 3.8
Combined NMES/TENS ProgramLower Extremity Strength- 30-Second Chair Stand TestWeek 613.6 risesStandard Deviation 3.9
Primary

Lower Extremity Strength- Timed Stair Climb Test

Strength, balance, and power were measured by the number seconds it took to ascend and descend 4 steps (6 in rise, 11.5 in run).

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolLower Extremity Strength- Timed Stair Climb TestWeek 03.7 SecondsStandard Deviation 1.1
Standard Rehabilitation ProtocolLower Extremity Strength- Timed Stair Climb TestWeek 33.6 SecondsStandard Deviation 0.8
Standard Rehabilitation ProtocolLower Extremity Strength- Timed Stair Climb TestWeek 63.4 SecondsStandard Deviation 0.6
Standard Rehabilitation ProtocolLower Extremity Strength- Timed Stair Climb TestWeek 93.3 SecondsStandard Deviation 0.7
Self-Managed NMES ProgramLower Extremity Strength- Timed Stair Climb TestWeek 33.7 SecondsStandard Deviation 1
Self-Managed NMES ProgramLower Extremity Strength- Timed Stair Climb TestWeek 63.5 SecondsStandard Deviation 1.1
Self-Managed NMES ProgramLower Extremity Strength- Timed Stair Climb TestWeek 93.5 SecondsStandard Deviation 1.2
Self-Managed NMES ProgramLower Extremity Strength- Timed Stair Climb TestWeek 04.0 SecondsStandard Deviation 1.4
Self-Managed TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 63.7 SecondsStandard Deviation 0.9
Self-Managed TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 33.8 SecondsStandard Deviation 1
Self-Managed TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 93.3 SecondsStandard Deviation 1
Self-Managed TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 04.2 SecondsStandard Deviation 1.4
Combined NMES/TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 93.4 SecondsStandard Deviation 0.9
Combined NMES/TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 33.6 SecondsStandard Deviation 1.3
Combined NMES/TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 04.1 SecondsStandard Deviation 1.6
Combined NMES/TENS ProgramLower Extremity Strength- Timed Stair Climb TestWeek 63.7 SecondsStandard Deviation 0.9
Secondary

Current Knee Pain

Current Knee Pain was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolCurrent Knee PainWeek 03.48 score on a scaleStandard Deviation 1.84
Standard Rehabilitation ProtocolCurrent Knee PainWeek 92.77 score on a scaleStandard Deviation 2.22
Standard Rehabilitation ProtocolCurrent Knee PainWeek 62.90 score on a scaleStandard Deviation 2.2
Standard Rehabilitation ProtocolCurrent Knee PainWeek 32.99 score on a scaleStandard Deviation 1.99
Self-Managed NMES ProgramCurrent Knee PainWeek 62.28 score on a scaleStandard Deviation 1.5
Self-Managed NMES ProgramCurrent Knee PainWeek 92.44 score on a scaleStandard Deviation 1.79
Self-Managed NMES ProgramCurrent Knee PainWeek 03.42 score on a scaleStandard Deviation 1.66
Self-Managed NMES ProgramCurrent Knee PainWeek 32.78 score on a scaleStandard Deviation 1.71
Self-Managed TENS ProgramCurrent Knee PainWeek 63.76 score on a scaleStandard Deviation 2.05
Self-Managed TENS ProgramCurrent Knee PainWeek 93.01 score on a scaleStandard Deviation 2.33
Self-Managed TENS ProgramCurrent Knee PainWeek 33.44 score on a scaleStandard Deviation 2.13
Self-Managed TENS ProgramCurrent Knee PainWeek 04.24 score on a scaleStandard Deviation 1.76
Combined NMES/TENS ProgramCurrent Knee PainWeek 93.27 score on a scaleStandard Deviation 2.26
Combined NMES/TENS ProgramCurrent Knee PainWeek 03.98 score on a scaleStandard Deviation 1.77
Combined NMES/TENS ProgramCurrent Knee PainWeek 62.72 score on a scaleStandard Deviation 1.8
Combined NMES/TENS ProgramCurrent Knee PainWeek 33.02 score on a scaleStandard Deviation 1.91
Secondary

Knee Pain Following Performance Testing- 30-Second Chair Stand Test

Knee pain intensity after the 30-Second Chair Stand Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 02.9 score on a scaleStandard Deviation 1.8
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 92.8 score on a scaleStandard Deviation 2.2
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 32.9 score on a scaleStandard Deviation 1.9
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 62.8 score on a scaleStandard Deviation 2.2
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 32.2 score on a scaleStandard Deviation 1.7
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 62.3 score on a scaleStandard Deviation 1.7
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 02.8 score on a scaleStandard Deviation 1.7
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 92.5 score on a scaleStandard Deviation 1.9
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 33.5 score on a scaleStandard Deviation 2
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 03.9 score on a scaleStandard Deviation 1.8
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 63.6 score on a scaleStandard Deviation 2.1
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 92.6 score on a scaleStandard Deviation 2.2
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 03.6 score on a scaleStandard Deviation 2
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 32.9 score on a scaleStandard Deviation 2.2
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 92.6 score on a scaleStandard Deviation 2.4
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 30-Second Chair Stand TestWeek 62.9 score on a scaleStandard Deviation 2.3
Secondary

Knee Pain Following Performance Testing- 6-Minute Walk Test

Knee pain intensity after the 6-Minute Walk Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 33.3 score on a scaleStandard Deviation 2
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 93.0 score on a scaleStandard Deviation 2.1
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 03.2 score on a scaleStandard Deviation 1.7
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 63.1 score on a scaleStandard Deviation 2.2
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 02.7 score on a scaleStandard Deviation 2.2
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 32.5 score on a scaleStandard Deviation 1.6
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 62.9 score on a scaleStandard Deviation 2.1
Self-Managed NMES ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 92.3 score on a scaleStandard Deviation 2
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 04.5 score on a scaleStandard Deviation 1.7
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 63.9 score on a scaleStandard Deviation 2.4
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 34.3 score on a scaleStandard Deviation 2
Self-Managed TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 92.9 score on a scaleStandard Deviation 2.3
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 33.2 score on a scaleStandard Deviation 2.2
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 62.6 score on a scaleStandard Deviation 1.9
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 92.7 score on a scaleStandard Deviation 2.5
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- 6-Minute Walk TestWeek 03.6 score on a scaleStandard Deviation 2.3
Secondary

Knee Pain Following Performance Testing- Forward Step Down Test

Knee pain intensity after the Forward Step Down Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Forward Step Down TestWeek 63.6 score on a scaleStandard Deviation 2.2
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Forward Step Down TestWeek 93.5 score on a scaleStandard Deviation 2.2
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Forward Step Down TestWeek 33.8 score on a scaleStandard Deviation 2
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Forward Step Down TestWeek 04.2 score on a scaleStandard Deviation 1.5
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 33.2 score on a scaleStandard Deviation 2
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 92.8 score on a scaleStandard Deviation 2.1
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 04.2 score on a scaleStandard Deviation 2.2
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 63.3 score on a scaleStandard Deviation 1.7
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 34.7 score on a scaleStandard Deviation 2
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 64.2 score on a scaleStandard Deviation 2.1
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 93.3 score on a scaleStandard Deviation 2.1
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 05.2 score on a scaleStandard Deviation 1.9
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 05.3 score on a scaleStandard Deviation 2.1
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 33.5 score on a scaleStandard Deviation 2.3
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 93.2 score on a scaleStandard Deviation 2.5
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Forward Step Down TestWeek 63.6 score on a scaleStandard Deviation 2.2
Secondary

Knee Pain Following Performance Testing- Stair Climb Test

Knee pain intensity after the Stair Climb Test was assessed using the Visual Analog Scale, an 11-point numerical rating scale. Participants rated current knee pain intensity on a scale of 0 (no pain) to 10 (worst pain imaginable). A mean pain score was calculated.

Time frame: 0, 3, 6, and 9 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Stair Climb TestWeek 02.7 score on a scaleStandard Deviation 1.9
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Stair Climb TestWeek 32.6 score on a scaleStandard Deviation 2.1
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Stair Climb TestWeek 62.7 score on a scaleStandard Deviation 2
Standard Rehabilitation ProtocolKnee Pain Following Performance Testing- Stair Climb TestWeek 92.7 score on a scaleStandard Deviation 2
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 32.3 score on a scaleStandard Deviation 1.5
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 62.1 score on a scaleStandard Deviation 1.7
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 92.0 score on a scaleStandard Deviation 1.8
Self-Managed NMES ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 02.7 score on a scaleStandard Deviation 1.8
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 63.6 score on a scaleStandard Deviation 2.3
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 33.4 score on a scaleStandard Deviation 2
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 92.7 score on a scaleStandard Deviation 2.3
Self-Managed TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 03.5 score on a scaleStandard Deviation 1.9
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 91.9 score on a scaleStandard Deviation 2.1
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 32.4 score on a scaleStandard Deviation 2.1
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 03.0 score on a scaleStandard Deviation 2.2
Combined NMES/TENS ProgramKnee Pain Following Performance Testing- Stair Climb TestWeek 62.2 score on a scaleStandard Deviation 2.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026